This protocol is judged by an institutional evaluation board, an independent team that critiques any clinical trials involving humans. If a study includes a Agenda I drug, after the board approves the protocol as moral, the researchers need to make an application for an investigational new drug (IND) selection with the FDA.Some scientists and corpo… Read More